France· FR:60045217
ZIMINO 2,5 mg/ml, solution à diluer pour perfusion
A levosimendan product containing lévosimendan, registered in France by ORION CORPORATION. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Levosimendan is registered in 14 of 19 countries.
Countries holding a registration under ATC C01CX08 (levosimendan), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Levosimendan · ATC C01CX08
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LÉVOSIMENDAN
- Manufacturer
- ORION CORPORATION
- Country
- France (FR)
- ATC code
- C01CX08
- ATC class
- Levosimendan
- Defined daily dose
- 11 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300210401 flacon(s) en verre de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levosimendan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsLevosimendan Eureco-Pharma 2,5 mg/ml, concentraat voor oplossing voor infusieEureco-Pharma B.V.
- SpainLEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- FinlandLevosimendan AltanAltan Pharma Ltd
- CzechiaLEVOSIMENDAN AVMCAV Medical CZ s.r.o., Praha
- SwedenLevosimendan Altan 2,5 mg/ml Koncentrat till infusionsvätska, lösningAltan Pharma Limited
- GermanyLevosimendan AccordAccord Healthcare B.V.
- PolandLevosimendan AccordAccord Healthcare Polska Sp. z o.o.
- SwitzerlandLevosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungIDEOGEN AG
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Cordenova, Levosimendan Accord
- Belgium · Levosimendan Kabi, Levosimendan Kalceks
- Bulgaria · Левосимендан Калцекс, Симдакс
- Cyprus · Levosimendan Win Medica, Simdax
- Czechia · Levosimendan Fmk, Levosimendan Kalceks
- Germany · Levosimendan Accord, Levosimendan Altan
- Denmark · Levosimendan, Levosimendan Amdipharm
- Estonia · Levosimendan Auxilia, Levosimendan Kalceks
- Spain · Levosimendán Accord, Levosimendán Altan
- Finland · Levosimendan Amdipharm, Levosimendan Bioglan
- Greece · Levosimendan Win Medica, Simdax
- Croatia · Levosimendan Alpha-Medical, Levosimendan Kalceks
- Hungary · Levosimendan Kalceks, Levosimendan Stada
- Ireland · Levosimendan Kalceks
- Iceland · Levosimendan Stada, Simdax
- Italy · Levosimendan Accord, Levosimendan Altan
- Lithuania · Levosimendan Kalceks
- Latvia · Levosimendan Kalceks
- Netherlands · Levosimendan Carinopharm, Levosimendan Kalceks
- Norway · Levosimendan Amdipharm, Levosimendan Bioglan
- Poland · Levosimendan Accord, Levosimendan Farmak
- Portugal · Levossimendano Accord, Levossimendano Altan
- Romania · Levatrop, Levosimendan
- Sweden · Levosimendan Amdipharm, Levosimendan Bioglan
- Slovenia · Levosimendan Carinopharm, Levosimendan Kalceks
- Slovakia · Levosimendan Fmk, Levosimendan Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcbbf6db-b243-4cf7-82e9-b899afc8fad2 GET /v1/drugs/bcbbf6db-b243-4cf7-82e9-b899afc8fad2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60045217",
"date_amm": "2015-10-20",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "LÉVOSIMENDAN",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about levosimendan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.